StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Quoin Pharmaceuticals's price to book ratio was 1.9× on Nov 11, 2026, against 1.7× a year earlier. Over the last 3 years it ranged from 0.1× to 3.2×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×−0.7
2025Oct 31, 20252.6×+2.0
2024Dec 31, 20240.6×−0.0
2023Dec 29, 20230.7×–

More Quoin Pharmaceuticals figures

See a number that looks wrong?